bladder cancer

2019 ASCO ® Annual Meeting; #ASCO19
June 3, 2019
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer

English
gregguthrie

The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.

Read More >>
2017 Clinical Cancer Advances
February 1, 2017
Greg Guthrie, ASCO staff

Immunotherapy 2.0: The 2017 Clinical Cancer Advance of the Year

English
gregguthrie

The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.

Read More >>
June 4, 2015
Cat Snyder, ASCO staff

Expert Conversations: Bladder Cancer

English
catherine.snyder

In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.

Read More >>
Subscribe to RSS - bladder cancer